TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) CFO Stephen Gordon sold 5,000 shares of the business’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $54.22, for a total transaction of $271,100.00. Following the completion of the transaction, the chief financial officer now owns 18,789 shares […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) has received a consensus rating of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price target […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report)’s share price gapped down before the market opened on Friday following insider selling activity. The stock had previously closed at $87.53, but opened at $76.50. TransMedics Group shares last traded at $78.59, with a volume of 498,566 shares traded. Specifically, insider Tamer I. Khayal sold 5,000 shares […]
TransMedics Group (NASDAQ:TMDX – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.12, Briefing.com reports. The business had revenue of $42.46 million during the quarter, compared to the consensus estimate of $42.42 million. TransMedics Group […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) insider Tamer I. Khayal sold 5,000 shares of TransMedics Group stock in a transaction dated Tuesday, July 18th. The shares were sold at an average price of $95.37, for a total value of $476,850.00. Following the transaction, the insider now owns 14,375 shares of the company’s stock, […]